If you have symptoms of fever, cough or difficulty breathing, have traveled to areas impacted by the Coronavirus (2019-nCoV) within the past 14 days, and/or have been in close contact with someone who has traveled outside the US or been exposed to the Coronavirus please call your primary clinic before coming in for your appointment. We have also made temporary changes to who may accompany patients to appointments and treatments. Learn More

About Us

NCI News

NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19
9/15/2020

NCI and the National Institute of Biomedical Imaging and Bioengineering have awarded seven contracts to develop digital health solutions, like smartphone apps, wearable devices, and software, that help address the COVID-19 pandemic.


NCI, Cancer Research UK launch Cancer Grand Challenges partnership to support bold new ideas for cancer research
8/27/2020

NCI and Cancer Research UK will partner to fund Cancer Grand Challenges, an international initiative to address profound and unanswered questions in cancer research.


New treatments spur sharp reduction in lung cancer mortality rate
8/12/2020

Mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen sharply in the United States in recent years, due primarily to recent advances in treatment, an NCI study shows.


AI dual-stain approach improved accuracy, efficiency of cervical cancer screening in NCI study
6/25/2020

In a new study, an automated dual-stain method using artificial intelligence improved the accuracy and efficiency of cervical cancer screening compared with the current standard for follow-up of women who test positive with primary HPV screening.


NIH scientists develop blood test to help improve liver cancer screening
6/11/2020

The new test is relatively simple and could improve screening for people who are at risk for developing hepatocellular carcinoma (HCC), the most common form of liver cancer. It could help doctors find and treat HCC early.


Study identifies potential approach to treat severe respiratory distress in patients with COVID-19
6/05/2020

As described in an NCI Media Availability, early data from a clinical study suggest that treatment with the cancer drug acalabrutinib provided clinical benefit to a small group of patients with severe COVID-19.


Study confirms effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
5/26/2020

In an NCI study, an alternative treatment regimen called dose-adjusted EPOCH-R that is less toxic than standard dose-intensive chemotherapy was highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status.


Higher daily step count linked with lower all-cause mortality
3/24/2020

In a new study, higher daily step counts were associated with lower mortality risk from all causes. Researchers found that the number of steps taken each day, but not the intensity of the stepping, had a strong association with mortality.


NCI statement on clinical trials during COVID-19 pandemic
3/19/2020

Statement from the National Cancer Institute providing information regarding treatment of cancer patients and participation in clinical trials during the COVID-19 pandemic.


NCI study provides genetic insights into osteosarcoma in children
3/19/2020

A new study offers insight into genetic alterations associated with osteosarcoma, the most common bone tumor of children and adolescents, and the findings have implications for genetic testing of children with osteosarcoma and their families.